BMS-303141 is an ATP citrate lyase (ACL) inhibitor with IC50 of 0.13 UM.

BMS-303141 is an ATP citrate lyase (ACL) inhibitor with IC50 of 0.13 UM. Struktur
CAS-Nr.
Englisch Name:
BMS-303141 is an ATP citrate lyase (ACL) inhibitor with IC50 of 0.13 UM.
Synonyma:
BMS-303141 is an ATP citrate lyase (ACL) inhibitor with IC50 of 0.13 UM.
CBNumber:
CB35767228
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

BMS-303141 is an ATP citrate lyase (ACL) inhibitor with IC50 of 0.13 UM. Eigenschaften

Sicherheit

BMS-303141 is an ATP citrate lyase (ACL) inhibitor with IC50 of 0.13 UM. Chemische Eigenschaften,Einsatz,Produktion Methoden

BMS-303141 is an ATP citrate lyase (ACL) inhibitor with IC50 of 0.13 UM. Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


BMS-303141 is an ATP citrate lyase (ACL) inhibitor with IC50 of 0.13 UM. Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Xiamen Research Biotechnology Co., Ltd. --
1562893815@qq.com CHINA 6936 58
Xiamen Huijia Biological Technology Co., Ltd. --
CHINA 6973 58
Hangzhou Yuxin Biotechnology Co., Ltd. --
haoxinbio@163.com CHINA 6595 58

  • BMS-303141 is an ATP citrate lyase (ACL) inhibitor with IC50 of 0.13 UM.
Copyright 2019 © ChemicalBook. All rights reserved